Cargando…
Outcomes of patients with cancer infected with SARS-CoV-2: results from the Ion Chiricuţă Oncology Institute series
BACKGROUND: The evolution of COVID-19 is a controversial topic in cancer patients. They have been designated by international organizations as a vulnerable population at greater risk for contracting SARS-CoV-2 and having a more severe clinical outcome. PATIENTS AND METHODS: Active screening at our i...
Autores principales: | Preda, A., Ciuleanu, T., Kubelac, P., Todor, N., Balacescu, O., Achimas-Cadariu, P., Iancu, D., Mocan, C., Bandi-Vasilica, M., Lupse, M., Briciu, V.T., Man, M.A., Vlad, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828430/ https://www.ncbi.nlm.nih.gov/pubmed/35279526 http://dx.doi.org/10.1016/j.esmoop.2022.100423 |
Ejemplares similares
-
Long-term survival following neoadjuvant chemotherapy and concomitant radiochemotherapy in locally advanced cervical cancer: results of the Oncology Institute "Prof. Dr. Ion Chiricuta" experience
por: Marita, Andreea, et al.
Publicado: (2018) -
Post-Treatment Thyroid Diseases in Children with Brain Tumors: A Single-Center Experience at “Prof. Dr. Ion Chiricuță” Institute of Oncology, Cluj-Napoca
por: Cosnarovici, Maria Margareta, et al.
Publicado: (2020) -
Evolutionary perspectives, heterogeneity and ovarian cancer: a complicated tale from past to present
por: Achimas-Cadariu, Patriciu, et al.
Publicado: (2022) -
Critical Aspects Concerning the Development of a Pooling Approach for SARS-CoV-2 Diagnosis Using Large-Scale PCR Testing
por: Cruceriu, Daniel, et al.
Publicado: (2021) -
Antiproliferative Ruthenium Complexes Containing Curcuminoid Ligands Tested In Vitro on Human Ovarian Tumor Cell Line A2780, towards Their Capability to Modulate the NF-κBTranscription Factor, FGF-2 Growth Factor, and MMP-9 Pathway
por: Leskovská, Janka, et al.
Publicado: (2022)